Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (11861)	6/1/2004 8:14:18 PM
From: tom pope	Read Replies (1) \| Respond to of 52153

This is funny. The stock is down 40%, but Feuerstein thinks a rating of neutral was the right call? Independent Research Group biotech analyst Jason Zhang also made the right call on Pozen and MT100, which he downgraded on April 6 to neutral from buy. Independent Research Group, which doesn't have a banking business, is a subsidiary of TheStreet.com (TSCM:Nasdaq - commentary - research), the publisher of this Web site